BRCA1 and posterior cortical atrophy: Men with germline BRCA1 or BRCA2 mutations have a three- to eight-fold higher lifetime risk of PCa that can behave aggressively because of additional MYC activation in combination with inactivation of TP53 and PTEN [52,53].